News & Media

Early diagnosis of ovarian cancer remains a challenge, but what if the answer lies in the smallest of clues?

EV-AAVs (sometimes known as exo-AAVs) offer enhanced gene therapy potential over solo-AAVs, thanks to improved transduction and targeted delivery. Obtaining highly purified EV-AAVs is crucial, with size-exclusion chromatography (SEC) proving to be a scalable and effective method for isolation.

Albumin is a contaminant of extracellular vesicle isolates, right? New research suggests that it may actually be part of the extracellular vesicle corona.

Check out some of the latest research employing qEV columns! A roundup of 10 articles making waves in the EV space.

Everything you need to know about MISEV2023 and how to meet it when publishing your qEV research.

Findings from five recent studies utilising the qEV10 column's benefits for important medical research.

Introducing the new qEV 20 nm Series, allowing you branch even further into the small end of the size spectrum and isolate more small particles than ever before.

Read about the role of qEV columns in recent stem cell EV discoveries.

A new tier of columns is now available: GMP-ready qEV columns.

An important notice about the planned phase out of qEV Legacy columns.

If you want the purest EV isolate which qEV column should you pick?

A deep dive into the approaches, considerations and pitfalls of labelling EVs.

A new approach to concentrating EVs after qEV isolation, featuring Magnetic Nanotrap® EV Capture Particles.

You know about extracellular vesicles, sure, but what about the new kids on the block? Exomeres and supermeres are here, and they are making a splash in the world of intercellular communication.

What does the future of extracellular vesicle isolation have in store, and how is Izon working towards that? Technology Networks speaks to Hans van der Voorn, CEO at Izon Science.

When it comes to yield, purity, expense and time commitment, does size exclusion chromatography or precipitation take the crown for EV isolation?

How can you be sure that the active ingredient in your extracellular vesicle therapeutic is actually in extracellular vesicles?

From Arabidopsis thaliana to red cabbage, the field of plant EV (and EV-like nanoparticle) research is a fast-changing world of basic biology and therapeutics. So why is methodology stuck in the past?

The collaborative agreement between Izon Science and ABT offers exceptional opportunities to develop solutions that aid in advancing EV research into clinical settings.

A summary of work by Hisey et al. (2022) who made a huge leap forward in EV production capacity via the use of flask-based bioreactors.

Has changing your isolation method changed your EV isolate bioactivity? Or perhaps even their cargo or markers? Here’s why.

100-packs now available for those looking to buy qEVoriginal Gen 2 columns in bulk.

When is an extracellular vesicle an exosome? Turns out, probably less often than you think. Here we delve into EV subtypes and the (lack of) markers to tell them apart.

A summary of work by Chiang et al. 2022, feat. qEV and TRPS for studying OMVs from a nosocomial bacterial pathogen.

Preeclampsia is a major contributor to premature birth. How might extracellular vesicles play a role in pathogenesis, prediction, and treatment?

The internal reproductive tract is a potential treasure trove of EVs for fields from assistive reproductive technologies to virology. In this article we discuss it all, from isolation to application.

Synovial fluid is a highly viscous biofluid containing immune cell-derived extracellular vesicles which could prove key to arthritides, but how should you isolate them? And what is already known about them?

A comparison of 5 isolation methods for milk extracellular vesicles: a summary of the findings of Morozumi et al. 2021.

Publications featuring Tunable Resistive Pulse Sensing (TRPS) from Q3, 2022.

Cerebrospinal Fluid presents unique challenges for EV isolation, which has been reflected in a lack of reproducibility in research.